Yılmaz Öztürk, R. Et Al. 2025. Nitidine and Paclitaxel co‐loaded lipid‐chitosan hybrid nanoparticles overcome ABCB1‐mediated multidrug resistance in ovarian cancer. CHEMMEDCHEM , vol.0, no.0 , 1-17.

Yılmaz Öztürk, R., Durası, E., Çalık, H., Arı Yuka, S., & Çakır, R., (2025). Nitidine and Paclitaxel co‐loaded lipid‐chitosan hybrid nanoparticles overcome ABCB1‐mediated multidrug resistance in ovarian cancer. CHEMMEDCHEM , vol.0, no.0, 1-17.

Yılmaz Öztürk, Rabia Et Al. "Nitidine and Paclitaxel co‐loaded lipid‐chitosan hybrid nanoparticles overcome ABCB1‐mediated multidrug resistance in ovarian cancer," CHEMMEDCHEM , vol.0, no.0, 1-17, 2025

Yılmaz Öztürk, Rabia Y. Et Al. "Nitidine and Paclitaxel co‐loaded lipid‐chitosan hybrid nanoparticles overcome ABCB1‐mediated multidrug resistance in ovarian cancer." CHEMMEDCHEM , vol.0, no.0, pp.1-17, 2025

Yılmaz Öztürk, R. Et Al. (2025) . "Nitidine and Paclitaxel co‐loaded lipid‐chitosan hybrid nanoparticles overcome ABCB1‐mediated multidrug resistance in ovarian cancer." CHEMMEDCHEM , vol.0, no.0, pp.1-17.

@article{article, author={Rabia Yılmaz Öztürk Et Al. }, title={Nitidine and Paclitaxel co‐loaded lipid‐chitosan hybrid nanoparticles overcome ABCB1‐mediated multidrug resistance in ovarian cancer}, journal={CHEMMEDCHEM}, year=2025, pages={1-17} }